Compare Koninklijke Philips NV (PHG) vs Plby Group Inc (PLBY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Koninklijke Philips NV vs Plby Group Inc — how do they compare? Koninklijke Philips NV trades at $24.94 (market cap $24.61B), while Plby Group Inc trades at $1.16 (market cap $138.38M). The key difference: Koninklijke Philips NV is far larger — about 177.8× Plby Group Inc's market cap, and Koninklijke Philips NV pays a 4.05% dividend while Plby Group Inc pays none. Which is the better fit depends on your goals.
| PHG | PLBY | |
|---|---|---|
Market Cap | $24.61B | $138.38M |
Sector | Health | Consumer Cyclical |
52-Week High | $32.91 | $2.71 |
52-Week Low | $25.02 | $1.11 |
Enterprise Value | $31.21B | $283.96M |
Dividend Yield | 4.05% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PHG trades at $25.29, down 2.32% today, with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with Q2 2026 EPS of $0.57 beating expectations of $0.40, and positive net income of $895M in 2025 reversing previous losses. Recent product launches in women's health and AI-powered medical devices demonstrate innovation momentum.
The outlook is mixed with strong fundamentals and analyst support (36% buy ratings) offset by technical weakness. Key opportunities include margin expansion and new product adoption, while risks involve cybersecurity threats and competitive pressures in healthcare technology.
PLBY trades at $1.18, up 0.85% with a bearish technical signal despite positive cash flow trends. The company shows improving fundamentals with revenue stabilizing around $120M and net losses narrowing significantly from -$278M in 2022 to -$13M in 2025. Recent Q2 2026 earnings beat expectations with a return to operating profitability, while analyst consensus remains strongly bullish with 75% buy ratings.
The outlook suggests cautious optimism as PLBY demonstrates operational turnaround with five consecutive quarters of positive EBITDA. Key risks include high debt levels and negative shareholder equity, but recent share repurchases and Russell index inclusion provide support. The stock faces resistance near current levels with technical indicators signaling caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →About Plby Group Inc
PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.
Read more on PLBY →
